Trials / Recruiting
RecruitingNCT06655012
Salmeterol Effect on Exercise Performance
The Muscle Anabolic Response to β2-adrenergic Stimulation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the project is to investigate the muscle anabolic response to acute beta2-adrenergic stimulation in young healthy men and women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salmeterol | Participants are administered 200 µg salmeterol (8 puffs) from a MDI device |
| DRUG | Placebo | Participants are administered placebo (8 puffs) from a MDI device |
Timeline
- Start date
- 2024-10-31
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-10-23
- Last updated
- 2025-04-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06655012. Inclusion in this directory is not an endorsement.